… a sizeable amount of individualized therapies. In this Review, we discuss the personalized
therapies for DTC that result in the best outcomes for patients with minimal adverse effects. …

… thyroid cancer (ATC) is the most lethal of all thyroid cancers … toward targeted, personalized
therapies is proving to be a … when developing novel therapies to improve the lives of patients. …

… , and cabozantinib, helps control tumor progression and prolongs … thyroid cancer, the
outcomes for most thyroid cancer patients are excellent compared with those for other cancers…

… With the new concept of personalized treatment of thyroid cancer diagnoses, planning
treatment, finding out how well treatment will work, and estimating a prognosis has changed for …

… of disease stabilization in patients with thyroid cancer is far from appreciation, as stable disease
(… the drugs developed against them in dedifferentiated thyroid cancer (DeDTC) (Table 1). …

… thyroid cancer (DTC) showed the need of a personalized management approach. Despite the
increased diagnosis of DTC, in particular small papillary thyroid cancers, cancer… of patients …

… (DTC), most commonly the papillary histotype, accounts for the majority of thyroid cancer …
radioiodine therapy (RaIT), and individualized thyroid hormone therapy tailored to the patient’s …

… ) and has the highest mortality rate of all the thyroid cancers. Until recently, this disease was
… the rationale for using systemic therapy in advanced thyroid carcinoma, listing the approved …

… Therefore, the key proteins might provide some added information for personalized therapy.
Recent research has confirmed that proteins are more stable than RNA in clinical tissues (80…

… The ATA published guidelines for thyroid nodules and well-differentiated thyroid cancer in
2006 and recommended routine CND for PTC, but failed to distinguish between therapeutic …